Ojjaara approved in the US as the first and only treatment for myelofibrosis patients with anaemia
Approval is for use in myelofibrosis patients with anaemia regardless of prior myelofibrosis therapy
Approval is for use in myelofibrosis patients with anaemia regardless of prior myelofibrosis therapy
Free Treatment, investigations and sex change surgery along with other facilities will be available at these OPDs for the Transgender community
Public private partnership (PPP) with integrated strategy essential to achieve ‘TB Mukt Bharat’ by 2025
Currently, Praveen Akkinepally is the Head of Lung Cancer Commercialization, AstraZeneca Gaithersburg, MD, USA
Sun Pharma is granted rights for marketing Sovateltide in India under the brand name Tyvalzi (Sovateltide)
The new logo incorporates three beating hearts seamlessly & reinforces 'healthcare with a heart' into the Group's visual identity
This advanced technology is specifically tailored for individuals with high power prescriptions, aiming to free the 18-35 age group from the reliance on eyeglasses
The product is expected to start contributing meaningfully to the revenue from FY25
The approval is for acquisition of up to 76.1% equity shares of Suven Pharmaceuticals by Berhyanda Limited
The company has received the Establishment Inspection Report (EIR) from the USFDA for the Pre-Approval Inspection (PAI) at a manufacturing site situated at Savli, Vadodara, Gujarat, with Zero 483 observations
Subscribe To Our Newsletter & Stay Updated